DEGARELIX ACETATE
| Brand name | FIRMAGON |
|---|---|
| Active ingredient | DEGARELIX ACETATE |
| Strength | EQ 80MG BASE/VIAL |
| Dosage form | POWDER |
| Route | SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | December 2008 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10695398 | April 2032 | use U-1895 |
| 11766468 | April 2032 | use U-1978 |
| 11826397 | April 2032 | use U-1978 |
| 9415085 | April 2032 | use U-1895 |
| 12533387 | February 2029 | use U-4417 |
| 12514898 | February 2029 | use U-1978 |
| 10973870 | February 2029 | use U-1978 |
| 9579359 | February 2029 | use U-1978 |
| 10729739 | February 2029 | use U-1978 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.